Commonwealth Equity Services
SBFM

Commonwealth Equity Services’s Sunshine Biopharma SBFM Stock Holding History

Commonwealth Equity Services’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14K Buy
+1,344
New +$15.8K ﹤0.01% 4271

Other funds holding SBFM

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Commonwealth Equity Services's SBFM Position: Q1 2026 in Review

Commonwealth Equity Services opened a new position in Sunshine Biopharma (SBFM) in Q1 2026: 1,344 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #4271 among its holdings.

8 funds tracked by Wall St. Rank hold SBFM as of Q1 2026.

  • Commonwealth Equity Services held 1,344 shares of Sunshine Biopharma worth $14K as of Q1 2026.
  • Sunshine Biopharma was a new Commonwealth Equity Services position in Q1 2026.
  • Sunshine Biopharma made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #4271 holding.
  • 8 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.